01—Abstract
Summary
Summary of the 10-Q filed July 30, 2025. Cited figures are marked; the original filing is the authoritative source.
Altria Group, Inc. (MO) reported a decrease in net earnings for the six months ended June 30, 2025, to $3.46 billiona from $5.93 billion in the prior year, primarily impacted by a significant gain in the prior year from the sale of IQOS System commercialization rights.
Reported diluted EPS also decreased to $2.04b from $3.41. Despite the decline in reported net earnings, adjusted net earnings saw an increase of 4.3% to $4.52 billion, with adjusted diluted EPS rising 7.2% to $2.67. This highlights the company's focus on operational performance and managing its core business segments.
The company continued its share repurchase program and maintained its progressive dividend goal, signaling a commitment to returning capital to shareholders. The results reflect ongoing industry challenges, including declining cigarette volumes and evolving consumer preferences towards smoke-free alternatives, alongside significant goodwill impairment related to the e-vapor segment.
02—Key points
Key Highlights
- Reported net earnings for the six months ended June 30, 2025, decreased to $3.46 billion from $5.93 billion in the prior year, largely due to a significant gain from the sale of IQOS System commercialization rights in the prior year.
- Adjusted net earnings increased by 4.3% to $4.52 billion for the first six months of 2025, while adjusted diluted EPS grew by 7.2% to $2.67, indicating operational strength.
- The company recorded an $873 million non-cash goodwill impairment charge in the first quarter of 2025 related to its e-vapor reporting unit, driven by U.S. International Trade Commission orders affecting NJOY ACE sales and other market factors.
- Net revenues for the six months ended June 30, 2025, decreased by 3.6% to $11.36 billion, with the smokeable products segment experiencing a 4.1% decline in net revenues.
- The oral tobacco products segment saw a 3.3% increase in net revenues to $1.41 billion for the six months ended June 30, 2025, driven by higher pricing, though shipment volumes declined.
- Altria continued its share repurchase program, repurchasing $600 million worth of shares in the first six months of 2025, and maintained its progressive dividend goal, signaling a commitment to shareholder returns.
- The company's investment in Anheuser-Busch InBev (ABI) remains a significant asset, with its fair value at $10.9 billion at June 30, 2025, though income from the investment declined due to a prior year gain and reduced ownership.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2025, Altria Group, Inc. kept $0.39.
- Revenue$6.10B100.0%
- Cost of revenue−$2.25B36.9%
- Gross profit$3.85B63.1%
- Operating costs−$620.0M10.2%
- Operating income$3.23B52.9%
- Interest, other & tax−$852.0M14.0%
- Net income$2.38B39.0%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2025filed July 30, 2025Financial Statements
Q2 FY2025 against Q2 FY2024
| Line item | Q2 FY2025Q2 FY2024 | Change |
|---|---|---|
| Revenue | $6.10B$6.21B | −1.7% |
| Cost of Revenue | $1.44B$1.60B | −10.1% |
| Gross Profit | $3.85B$3.67B | +4.8% |
| Operating Income | $3.23B$2.53B | +27.5% |
| Net Income | $2.38B$3.80B | −37.5% |
| EPS (Basic) | $1.41$2.21 | −36.2% |
| EPS (Diluted) | $1.41$2.21 | −36.2% |
| Shares Outstanding (Basic) | 1.68B1.72B | −2.0% |
| Shares Outstanding (Diluted) | 1.68B1.72B | −2.0% |
05—Questions
Frequently Asked Questions
What is the primary driver for the decrease in reported net earnings for the six months ended June 30, 2025?
The primary driver for the decrease in reported net earnings was a significant one-time gain of $2.7 billion recognized in the prior year (six months ended June 30, 2024) from the sale of IQOS System commercialization rights. Excluding this and other special items, adjusted net earnings actually increased.
What led to the goodwill impairment charge in the e-vapor segment?
Altria recorded an $873 million non-cash goodwill impairment charge for its e-vapor reporting unit due to U.S. International Trade Commission (ITC) exclusion and cease-and-desist orders prohibiting the importation and sale of NJOY ACE in the United States, combined with lower projected volumes and higher costs associated with product commercialization.
How is the company addressing the decline in cigarette volumes?
Altria is focused on its 'Moving Beyond Smoking™' strategy, which involves responsibly transitioning adult smokers to smoke-free products, competing for adult nicotine consumers, and exploring new growth opportunities. This includes investing in its oral nicotine pouch brand 'on!' and e-vapor products, while also managing its core smokeable products segment through pricing actions and cost management.
What is the outlook for shareholder returns, specifically dividends and share repurchases?
Altria continues to prioritize shareholder returns. It paid $3.45 billion in dividends in the first six months of 2025 and has a progressive dividend goal targeting mid-single digits annual growth. The company also repurchased $600 million worth of shares in the first six months of 2025 under its authorized share repurchase programs, indicating ongoing commitment to both dividends and buybacks.
06—Continue